Literature DB >> 15083558

Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.

Philip W Appel1, Aletha A Ellison, Hadley K Jansky, Rivka Oldak.   

Abstract

Alcohol and other drug abuse (AOD) treatment is a major means of HIV/AIDS prevention, yet clients of street outreach programs (SOP) who are injection drug users (IDU), and outreach workers and staff as well, report various obstacles to enrolling clients in AOD programs. This study assessed the barriers to AOD enrollment facing high risk street outreach clients and obtained suggestions for reducing them. Data were obtained from semistructured field interviews with: 1) IDU outreach clients (N = 144) of the six SOPs in New York City (NYC) and northern suburbs supported by the Office of Alcoholism and Substance Abuse Services (OASAS), the single state agency in New York State for AOD prevention and treatment, 2) outreach workers and staff of the six SOPs (N = 55), 3) staff of detox and AOD treatment programs in major modalities treating IDUs (N = 71), and 4) officials and administrators (N = 11) in OASAS, the AIDS Institute of the Department of Health (addresses all aspects of the HIV/AIDS epidemic in New York State), and the agency for public assistance in New York City, the Human Resources Administration (HRA). Principal barriers for street outreach clients included personal-family issues, lack of insurance/Medicaid, ignorance, suspicion, and/or aversion to AOD treatment (methadone maintenance especially), "hassles" with Medicaid, lack of personal ID, lack of "slots," limited access to intake, homelessness, childcare-child custody issues. Further, about 18% had no desire for AOD services, reported no barriers, or were too enmeshed in addiction to enroll. Outreach staff cited prospective client's lack of ID and lack of Medicaid, lack of "slots," and stakeholder agency bureaucracy. Treatment staff cited lack of client readiness, "hassles" posed by welfare reform, AOD programs' own "red tape," waiting lists, and near exclusionary preference for the Medicaid-eligible. Finally, agency managers cited client factors, inadequate funding and lack of appropriate programs, treatment program requirements, and societal stigmatization of addicts. Proposed remedies included dropping ID and insurance requirements for admission, major increases in resources, funding the transporting of outreach client treatment candidates to AOD services sites, education and training initiatives, increased inter-agency cooperation, and the need for stakeholder agencies, OASAS especially, to more effectively integrate abstinence-oriented AOD services with harm reduction and the public health aspects of AOD problems.

Entities:  

Mesh:

Year:  2004        PMID: 15083558     DOI: 10.1081/ada-120029870

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  86 in total

1.  Spatial patterns of arrests, police assault and addiction treatment center locations in Tijuana, Mexico.

Authors:  Dan Werb; Steffanie A Strathdee; Alicia Vera; Jaime Arredondo; Leo Beletsky; Patricia Gonzalez-Zuniga; Tommi Gaines
Journal:  Addiction       Date:  2016-04-28       Impact factor: 6.526

2.  Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders.

Authors:  Ramin Mojtabai; Lian-Yu Chen; Christopher N Kaufmann; Rosa M Crum
Journal:  J Subst Abuse Treat       Date:  2013-08-29

3.  Medicaid coverage and access to publicly funded opiate treatment.

Authors:  Dennis D Deck; Wyndy L Wiitala; Katherine E Laws
Journal:  J Behav Health Serv Res       Date:  2006-07       Impact factor: 1.505

4.  Social contextual factors associated with entry into opiate agonist treatment among injection drug users.

Authors:  Jacqueline J Lloyd; Erin P Ricketts; Steffanie A Strathdee; Llewellyn J Cornelius; David Bishai; Steven Huettner; Jennifer R Havens; Carl Latkin
Journal:  Am J Drug Alcohol Abuse       Date:  2005       Impact factor: 3.829

5.  Treatment barriers identified by substance abusers assessed at a centralized intake unit.

Authors:  Richard C Rapp; Jiangmin Xu; Carey A Carr; D Tim Lane; Jichuan Wang; Robert Carlson
Journal:  J Subst Abuse Treat       Date:  2006-04

6.  Individual and system influences on waiting time for substance abuse treatment.

Authors:  Carey J A Carr; Jiangmin Xu; Cristina Redko; D Timothy Lane; Richard C Rapp; John Goris; Robert G Carlson
Journal:  J Subst Abuse Treat       Date:  2007-05-23

7.  Access to drug abuse treatment under Treatment on Demand policy in San Francisco.

Authors:  James L Sorensen; Joseph Guydish; Pamela Zilavy; Thomas B Davis; Alice Gleghorn; Marvin Jacoby; Clare Sears
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

8.  Factors related to psychosocial barriers to drug treatment among Chinese drug users.

Authors:  Brian C Kelly; Tieqiao Liu; Guanbai Zhang; Wei Hao; Jichuan Wang
Journal:  Addict Behav       Date:  2014-04-13       Impact factor: 3.913

9.  Transitioning From Detoxification to Substance Use Disorder Treatment: Facilitators and Barriers.

Authors:  Christine Timko; Nicole R Schultz; Jessica Britt; Michael A Cucciare
Journal:  J Subst Abuse Treat       Date:  2016-07-29

10.  Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression.

Authors:  Lian-Yu Chen; Eric C Strain; Rosa M Crum; Ramin Mojtabai
Journal:  J Addict Med       Date:  2013 Sep-Oct       Impact factor: 3.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.